Why Standard GAAP Accounting Might Be Depressing Your Valuation
For healthcare IT and MedTech founders, relying solely on GAAP EBITDA can be an incredibly expensive mistake.
When preparing for an M&A process or a major capital raise, standard accounting often paints an incomplete picture of your true profitability. It’s not because the business is weak; it’s because standard GAAP rules frequently force you to expense the very innovations that drive your long-term value.
If you are preparing for a transaction, here is how you should actually be looking at your R&D costs to maximize valuation.
1. Digital Health: Stop Expensing Your Software Build
Under GAAP, you are legally permitted to capitalize software development costs once technical feasibility is established. Yet, far too many bootstrap or early-stage HCIT teams simply expense everything by default because it’s easier. By failing to capitalize these costs, you are artificially suppressing your EBITDA on paper.
2. MedTech & Biotech: The Power of the "Non-GAAP" Bridge
In medical device and biotech manufacturing, GAAP mandates that R&D must be expensed. However, if your platform already has commercial traction, dollar-for-dollar expensing hides your true earnings power.
To fix this, sharp founders utilize a Non-GAAP Adjusted EBITDA bridge during marketing. As long as your methodology is transparent, consistent, and audit-ready, institutional buyers accept these adjustments because it matches product development costs to the actual revenue they generate.
The Math: How Pro-Forma Adjustments Impact Enterprise Value
Consider how a standard mid-market healthcare multiplier turns an accounting adjustment into actual wealth:
GAAP EBITDA: $5.0M
Capitalized R&D Adjustment: +$3.0M
Less Amortization: ($0.6M)
Adjusted Pro-Forma EBITDA: $7.4M
At a hypothetical 12x market multiple, that $2.4M accounting adjustment represents an additional $28.8M in enterprise value at the closing table.
The Bottom Line
Sophisticated private equity investors and strategic acquirers will eventually run this math during underwriting anyway. However, presenting a clean, well-supported Adjusted EBITDA bridge from day one shifts the narrative. It proves you understand the economic reality of your platform and sets a higher floor for initial bids.
If you are planning an exit or recapitalization in the next 12 to 24 months, your accounting preparation needs to start now. Let’s connect to look at your current numbers and ensure you aren't leaving money on the table.